EverHint – EMA 10/30 Crossover – Top 15 Buy and Top 5 Sell Signals for Aug 25, 2026
Excerpt: 20 signals (from 50 total). Industrials leads (13). price range $3-$356. 1 with insider selling.
What This Signal Is
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
Market Context
Equity markets are posting modest but broad-based gains on August 25, 2026, with the Nasdaq leading the advance at +0.66%, suggesting that growth and technology-oriented names are attracting incremental buying interest. The S&P 500 and Dow Jones are moving in lockstep at +0.30%, pointing to a measured, risk-on tone rather than a speculative surge. This kind of steady, orderly upside is generally constructive for trend-following strategies like EMA crossovers, as price action tends to respect moving average levels rather than whipsawing through them.
Volatility conditions are notably supportive for the current signal set. The VIX at 15.46, down nearly 2.5% on the session, sits in a low-to-moderate range that historically reduces the frequency of false breakouts. When implied volatility compresses, intraday price swings narrow, which means EMA-based crossover signals carry a higher probability of follow-through rather than reversing within the same session. Traders can generally afford slightly wider stop placements in this environment without sacrificing risk-reward efficiency.
The dominance of Industrials among today's top signals is worth noting from a sector rotation perspective. Industrials tend to outperform during mid-to-late cycle economic phases when capital expenditure and infrastructure demand remain resilient. Their leadership alongside a calm VIX and positive index breadth suggests the market is rewarding economically sensitive, fundamentals-driven sectors over purely defensive positioning. This rotation dynamic aligns well with momentum-based EMA strategies, as trending sectors tend to produce cleaner, more sustained signals than those experiencing mean-reversion or sector-specific headwinds.
🟢 Buy Signals (15 of 16 total)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | BEAM | Beam Therapeutics Inc. | Healthcare | $31.03 | — | $3.2B |
| 2 | CVNA | Carvana Co. | Consumer Cyclical | $75.75 | — | $83.1B |
| 3 | EXEL | Exelixis, Inc. | Healthcare | $56.72 | — | $14.3B |
| 4 | GSK | GSK plc | Healthcare | $52.07 | — | $104.3B |
| 5 | HIMS | Hims & Hers Health, Inc. | Consumer Defensive | $31.75 | — | $7.1B |
| 6 | IONS | Ionis Pharmaceuticals,... | Healthcare | $63.57 | — | $10.6B |
| 7 | KD | Kyndryl Holdings, Inc. | Technology | $13.02 | — | $2.9B |
| 8 | KRYS | Krystal Biotech, Inc. | Healthcare | $356.19 | — | $10.5B |
| 9 | LOPE | Grand Canyon Education... | Consumer Defensive | $149.08 | — | $3.9B |
| 10 | NNE | Nano Nuclear Energy Inc. | Industrials | $19.24 | — | $1.0B |
| 11 | NTLA | Intellia Therapeutics,... | Healthcare | $13.51 | — | $1.9B |
| 12 | RZLV | Rezolve AI PLC | Technology | $2.96 | — | $1.2B |
| 13 | SBAC | SBA Communications Cor... | Real Estate | $187.62 | — | $19.9B |
| 14 | SMR | NuScale Power Corporation | Industrials | $9.80 | — | $2.9B |
| 15 | XP | XP Inc. | Financial Services | $17.80 | — | $9.3B |
🔴 Sell Signals (5 of 34 total)
Ranked by RSI (higher RSI for sell signals = more overbought)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AAOI | Applied Optoelectronic... | Technology | $113.15 | — | $9.1B |
| 2 | AIR | AAR Corp. | Industrials | $135.27 | — | $5.4B |
| 3 | AVAV | AeroVironment, Inc. | Industrials | $147.42 | — | $7.5B |
| 4 | AVT | Avnet, Inc. | Technology | $87.57 | — | $7.2B |
| 5 | BPOP | Popular, Inc. | Financial Services | $169.55 | — | $10.8B |
Field Notes
Sector concentration: Industrials (13), Healthcare (9), Technology (8)
Data coverage: 2.0% insider (7d), 0.0% congressional (30d), 0.0% earnings, 12.0% news (7d)
Peer Analysis
AAOI (Applied Optoelectronics, Inc.): Leads 5 peers: DQ ($14.21), KLIC ($84.53), VSH ($31.31), MXL ($66.36), VECO ($47.59)
NTLA (Intellia Therapeutics, Inc.): Leads 5 peers: ZBIO ($33.77), PHVS ($37.23), UPB ($7.18), SYRE ($107.36), BHVN ($14.38)
Recent Headlines
AAOI (Applied Optoelectronics, Inc.)
- AAOI Benefits From Strong 800G Demand: Can It Beat LITE & COHR?
- Applied Optoelectronics: Investors Are Over-Discounting Growth Prospects
- Why Applied Optoelectronics Stock Dived by Almost 14% on Monday
AIR (AAR Corp.)
- Avcon Delivers King Air B200 Mosquito Control Aircraft Modification
- Buy 3 Mid-Sized Defense Equipment Stocks Amid Geopolitical Conflicts
AVAV (AeroVironment, Inc.)
- Here's Why AeroVironment (AVAV) Fell More Than Broader Market
- AeroVironment Stock Drops Despite $100 Million Investment
AVT (Avnet, Inc.)
- 5 Broker-Adored Stocks to Watch as Iran-U.S. Tensions Refuse to Fade
Vlad's Take
Today's signals: Strong sector concentration in Industrials (13 signals) suggests sector-specific rotation.
Trading tips for this strategy:
- Entry timing: Enter on pullback after crossover or at crossover close price
- Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
- Stop loss: Below recent swing low for buys, above recent swing high for sells
- Take profit: 5-10% target for swings, or trail stop at EMA10
- Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)
Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.